Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Transplant: An Analysis from ECOG 2993/MRC UK ALLXII.
Adults with acute lymphoblastic leukemia (ALL) have a poorer prognosis than children due to a high risk of relapse. One explanation may be variable adherence to dose-intense chemotherapy. However, little is known about risk factors for delays in therapy and their impact on survival. We conducted an...
主要な著者: | Kumar, A, Gimotty, P, Gelfand, J, Buck, G, Rowe, J, Goldstone, A, Fielding, A, Marks, D, Litzow, M, Paietta, E, Lazarus, H, Tallman, M, Luger, S, Loren, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2016
|
類似資料
-
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
著者:: Fielding, A, 等
出版事項: (2010) -
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
著者:: Fielding, A, 等
出版事項: (2010) -
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
著者:: Fielding, A, 等
出版事項: (2010) -
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
著者:: Sive, J, 等
出版事項: (2012) -
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
著者:: Fielding, A, 等
出版事項: (2007)